Introduction
An example of an almost ideal virus-host relationship where both survive and thrive without virus being eliminated or the host suffering from acute viral or immunopathological disease may be found in certain combinations of different mouse strains and various lymphocytic choriomeningitis virus (LCMV) isolates. LCMV, a non-cytopathic RNA virus, induces in its natural host the mouse, a strong cytotoxic T lymphocyte (CTL) response restricted by class I MHC molecules.
* Author for correspondence. Present address: Division of Molecular Immunology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA. Fax +44 81 906 4477. This CTL response is protective but under selected conditions a lethal immunopathology is induced in immunocompetent mice (Lehmann-Grube, 1971 ; Hotchin, 1971; Cole et al., 1972; Gilden et al., 1972; Zinkernagel & Doherty, 1979; Byrne & Oldstone, 1984; Moskophidis et al., 1987b) . The infection of embryos by their infected mothers, or of neonatal mice by LCMV inoculation results in lifelong persistence of the virus by deletion of immature antiviral T cells in the thymus (Cihak & Lehmann-Grube, 1978; Ahmed et al., 1984; Pircher et al., 1989) . Previous studies revealed that LCMV-Docile or C1 13-Armstrong persist in immunologically competent mice acutely infected with a relatively high dose, or in certain mouse strains even after infection with a low virus inoculum of 101 or 102 p.f.u, intravenously (i.v.) (Moskophidis et al., 1993b (Moskophidis et al., , 1994b Ahmed et al., 1984) . These virus variants were isolated from a congenital LCMV-WE (UBC) and an Armstrong carrier mouse (Pfau et al., 1982; Ahmed et al., 1984) , respectively. In a recent report, we have demonstrated that rapid replication of LCMV-Docile in a broad range of host tissues initially induced a vigorous proliferative CTL response followed by deletion of antiviral CTL resulting in virus persistence (Moskophidis et al., 1993a) . The present study attempted to evaluate parameters of LCMV C1 13-Armstrong and its parental strain Armstrong. These viruses have previously been analysed in vivo and in detail at the molecular level (Ahmed et al., 1988b; Salvato et al., 1988 Salvato et al., , 1991 Matloubian et al., 1990) with respect to parameters leading to persistence. The findings here show that the capacity of C1 13-Armstrong to exhaust CTLs, but apparently not T helper cells in H-2 b mice, lies between those of LCMV-WE and LCMV-Docile (which exhausts CTLs most readily). This study demonstrates that the route of infection is an important factor influencing the establishment of a persistent virus infection in immunocompetent mice by exhaustion of CTL.
Methods
Experimental animals and viruses. C57BL/6 (H-2 b) mice were obtained from the Institut ffir Zuchthygiene (University of Zfirich, Switzerland). The generation of efl-T cell receptor transgenic (TCR-tg) mice expressing Ve2/Vfl8 from P14 CTL clone specific for aa 32-42 of LCMV glycoprotein 1 (LCMV-GP1) in association with H-2D b has been described previously (Pircher et al., 1989) .
LCMV-WE was obtained from Dr F. Lehmann-Grube (Hamburg, Germany) and LCMV-Docile and Aggressive [variants isolated from a LCMV-WE(UBC)-carrier mouse] were obtained from Dr C. J. Pfau (Troy, New York) as a plaque-purified second passage virus (Pfau et al., 1982) . LCMV-8.7 exhibits an amino acid change at position 35 (Val ~ Leu) in the transgenic T cell epitope (aa 32-42 of LCMV-GP1) and therefore LCMV-8.7-infected H-2 b target cells are not lysed by TCR-tg effector cells (Pircher et al., 1990) . CI 13-Armstrong is a variant isolated from spleen cells of an adult BALB/WEHI mouse neonatally infected with LCMV-Armstrong. Both the original LCMV-Armstrong and C1 13-Armstrong were obtained originally from Dr M. B. A. Oldstone (Scripps Clinic and Research Foundation, La Jolla) (Dutko et al., 1983) and Dr R. Ahmed (UCLA, Los Angeles) (Ahmed et al., 1984) . Second passage virus derived from plaque-purified isolates was propagated on BHK cells (Armstrong and C1 13-Armstrong) or L929 fibroblast cell (WE) or MDCK cells (Docile). The viruses were titrated on L929 cell monolayer cultures (Lehmann-Grube et al., 1985) or with an immunological focus assay (Battegay et al., 1991) . The sensitivity of the immunological focus assay is 2 to 3-fold less sensitive than virus titres detected by in vivo infection. The quantification of infectious virus in mouse tissues has been described in detail previously (Lehmann-Grube et al., 1985) .
Detection of antiviral CTL precursor cells & the spleen of mice infected
with LCMV variants. Antiviral CTL precursor (CTL-p) activity was determined under limiting dilution conditions as has been described in a previous report (Moskophidis et al., 1987a) with minor modifications. Limiting numbers of responder cells were cultivated in 96-well roundbottom plates with irradiated (30 Gy) LCMV-infected peritoneal macrophages as stimulators (104 cells/well) in Iscove's modified Dulbecco's medium conditioned with interleukins (supernatant from Con A-stimulated rat spleen cells). After 7 days incubation, the CTL activities in the microcultures were determined on MC57G (H-2 b) target cells infected with LCMV or uninfected controls. The antiviral CTL-p frequencies were calculated according to Taswell (1981) and were expressed as total CTL-p numbers per spleen.
Cytofluorometric and functional analysis. An optimal number (103) TCR + transgenic lymph node T cells specific for LCMV aa 32-42 and presented by MHC-2D b molecules were transferred together with 107 p.f.u, of LCMV C1 13-Armstrong into C57BL/6J recipient mice to compare kinetics of endogenous and transferred transgenic CTL.
Transgenic TCR + CD8 + T cells were detected directly (before restimulation in vitro) by flow cytometric analysis using TCR-specific monoclonal antibodies (MAbs) (triple staining for Vc~2, Vfl8 and CD8). Spleen cells were first incubated with nnconjugated anti-Vc~2 MAb (Pircher et al., 1992) followed by phycoerythrin (PE)-conjugated goat anti-rat immunoglobulin (Southern Biotechnology). After a blocking step with normal rat immunoglobulin, the staining was completed with anti-CD8-FITC (Becton Dickinson) and biotinylated anti-Vfl8 (Pharmingen) and revealed by avidin-RED 613 (Gibco BRL). Viable cells were gated by a combination of forward light scatter and 90 ° side scatter and were analysed on an EPICS profile analyser (Coulter) with a scale extending over 4 log10 arbitrary fluorescent intensity units.
The function of transferred cells was evaluated in the same spleen cells used for direct staining by determining their antiviral CTL capacity after restimulation in vitro. Various numbers of spleen cells (4 x 106 to 1.25 × 105 cells/well) were cultured for 5 days in 24-well plates with irradiated LCMV-infected macrophages as stimulators (5 x 105 cells/well) in medium containing 10 % supernatant of Con Astimulated rat spleen cells. The CTL activity was determined in a 4-5 h ~lCr release assay on MC57G (H-2 b) target cells uninfected or infected with LCMV C1 13-Armstrong or 8.7. The CTL activity was expressed as lytic units (LU) per spleen (Zinkernagel et al., 1985) . Virus titres were determined in the spleen and thymus of the same LCMV C1 13-Armstrong-infected recipients of transgenic TCR + T cells or of virusinfected controls.
Local LCMV-induced #nmunopathology. The LCMV-specific footpad swelling after local inoculation of LCMV into feet has been described in detail previously (Moskophidis & Lehmann-Grube, 1989) . Lymphocytic choriomeningitis was induced by intracerebral (i.c.) inoculation of LCMV (Lehmann-Grube, 1971 ). Mice were monitored twice daily for 20 days.
Enumeration of LCMV-specific antibo@-forming cells. The method for detection of antiviral antibody-forming cells (AFC) in spleens of mice infected with various LCMV variants has been described in detail previously (Moskophidis & Lehmann-Grube, 1984) . Briefly, spleen cells were serially diluted and seeded onto LCMV-coated plates. After 5 h incubation at 37 °C the cells were removed by rinsing the wells with PBS containing 0.5 % Tween-20. Optimally diluted rabbit anti-mouse IgM or IgG serum was added and the mixture was incubated for 2 h at 37 °C. The wells were rinsed again, and an antibody-alkaline phosphatase conjugate was added. The plates were left at room temperature overnight, and after further washing, 5-bromo-4-chloro-3indolylphosphate-containing agarose was added to each well. Blue spots corresponding to AFC were counted after incubation for 1 h at 37 °C. Partial sequence analysis of LCMV isolates. LCMV-Docile or Aggressive was purified from the supernatant of cell cultures using a procedure described previously (Peralta & Lehmann-Grube, 1981) . Viral RNA was isolated by digestion with proteinase K, phenolchloroform extraction and sequential precipitation with ethanol. The RNA was dissolved in water and quantified by spectrophotometry. Viral RNA (2 gg) was then used as a template for cDNA synthesis using reverse transcriptase (Moloney murine leukaemia virus; Pharmacia) using the manufacturer's conditions and specific primers.
I. 5'-GGTACCGATAGCTTGTTTGGCTGCACC-3' complementary to nucleotide positions 733 759 in the viral S-RNA and amplifying region including the CTL epitope aa 32-42 of the LCMV-GP1.
II. 5'-TCGTAGCATGTCACAGAATTCTTC-Y complementary to nucleotide positions 1014~1037 in the viral S-RNA and amplifying region including the CTL epitope aa 275~86 of LCMV-GP2.
III. 5'-GAGAGGCCTCAAGCTTCTGGAGT-3' complementary to nucleotide positions 2945 2967 of the viral S-RNA and amplifying region of the nucleoprotein including the CTL epitope aa 397-405.
The cDNA was amplified by PCR using Taq polymerase (Boehringer, Mannheim) with primer I and IV (5'-AGGACAACTGGGTGCTG-GATT-Y, corresponding to nucleotide 42 62 of the viral S-RNA) or with primer II and V (5'-GAATTCTATCCAGTAAAAGGATGG-3', corresponding to nucleotide 58 81 of the viral S-RNA) or with primer III and VI (5'-GGGAGAGCACCTATAACTGATGAGG-Y, corresponding to nucleotide 1976-2000 of the viral S-RNA). PCR was run for 42 cycles on a thermal cycler (Perkin Elmer). Denaturation was carried out for 1 min at 94 °C, annealing for 1.5 min at 42 °C and extension for 3 min at 72 °C. The PCR products were isolated from agarose gels using Millipore filters (QTY UF OHV25 ultrafree MC 0.45ram; Pharmacia) and sequenced with a Taq dyedeoxy-terminator cycle sequencing kit on an Applied Biosystems DNA sequencing system 373A according to the manufacturer's conditions. To avoid PCR artefacts, viral RNA was sequenced from at least four independent virus preparations. In addition both strands were sequenced using suitable primers. Sequences were compared to those for WE, Armstrong or CI 13-Armstrong described previously (Romanowski et al., 1985; Salvato et al., 1988) .
Results
Variables determining the outcome of LCMV C1 13-Armstrong infection in C57BL/6 mice C57BL/6 mice were infected (i.v.) with different doses of LCMV C1 13-Armstrong or Armstrong; alternatively mice received a relatively high dose (106-107 p.f.u.) of LCMV-Docile or WE (Moskophidis et al., 1993b) . The virus titres were determined in the spleen ( Fig. 1 a, upper panels), thymus ( Fig. 1 a, lower panels) or in the kidneys (Fig. 1 c) .
LCMV was cleared by day 15 post-infection (p.i.) from all tested tissues of mice infected i.v. with 102 or 107 p.f.u. of LCMV-Armstrong or 107 p.f.u, of LCMV-WE. By contrast, infection with LCMV C1 13-Armstrong led to prolonged persistence of the virus in tissues of the host, depending on the dose of infection. Mice infected with 102 p.f.u, of LCMV C1 13-Armstrong cleared the virus quickly (on day 15 p.i. from spleen or day 8 p.i. from thymus), whereas an inoculum of 104 p.f.u, was not cleared until day 40 p.i. and an inoculum of 107 p.f.u. even persisted until day 100 p.i. After infection with 107 p.f.u., virus persisted for longer than 200 days in kidneys (Jamieson et al., 1991) . These findings differed from those with LCMV-Docile (107 p.f.u.) where LCMV persisted for life in most tissues of the host.
Because class I-restricted antiviral CTL are necessary for virus clearance after an acute LCMV infection, the antiviral CTL immune response was studied in the spleens of the same mice by determining the total numbers of antiviral CTL-p ( Fig. 1 b) . C57BL/6 mice, which eliminate the LCMV isolates LCMV-Armstrong (102 or 107 p.f.u.), WE (107 p.f.u.) or LCMV C1 13-Armstrong (102p.f.u.), exhibited kinetics of CTL-p peaking around day 6 to day 10 p.i. The levels of antiviral memory CTLs were around 105 CTL-p per spleen on day 15 p.i. By contrast, inoculation i.v. of 104 p.f.u, of LCMV C1 13-Armstrong initially led to extensive expansion of the antiviral CTL-p (maximum values around day 6 to 10 p.i.); these then rapidly declined to low levels around day 18 p.i. However, the numbers of CTL-p later increased with frequencies on day 250 p.i. comparable to those measured during the acute phase of the infection (e.g. on day 6 p.i.) and about 10-30-fold higher than found during memory states after inoculation of 102 p.f.u.i.v, of C1 13-Armstrong. Infection of C57BL/6 mice i.v. with 107 p.f.u, of LCMV C1 13-Armstrong caused a drastic decline of the antiviral CTL-p between day 18 and day 40 p.i., followed by an increase of the antiviral CTL-p. By day 250 after infection numbers of CTL-p were comparable to those detected in mice mounting a normal antiviral memory response after infection with 107p.f.u. of LCMV-Armstrong. As shown previously, in C57BL/6J mice infected with 107 p.f.u, of LCMV-Docile, the antiviral CTL-p expanded vigorously, followed by complete deletion by day 15 p.i. and were not detectable thereafter ( Fig. 1 b) . Infection with LCMV-WE or Aggressive, led to development of a memory CTL response and rapid elimination of the virus (Fig. 1 a, b and data not shown) after infection with 10 v p.f.u.i.v.
Incomplete clonal deletion of the peripheral antiviral CTLs in C57BL/6 mice infected with 107 p.f.u, of LCMV Cl 13-Armstrong
To evaluate whether the decline of the antiviral CTL-p in mice infected with LCMV C1 13-Armstrong (107 p.f.u.) reflected either anergy (Schwartz, 1990; Herman et al., 1991) , receptor or coreceptor down-regulation (Sch6nrich et al., 1991 ; Rocha & von Boehmer, 1991) or deletion (Webb et al., 1990; Rocha &von Boehmer, 1991) of LCMV-specific CTL-p, adoptive transfer experiments were performed using donor T cells from mice expressing a transgenic LCMV-specific TCR (Pircher et al., 1990) as indicator T cells. For this purpose an optimal number (103) TCR+-tg spleen cells were transferred together with 107p.f.u. of LCMV C1 13-Armstrong into C57BL/6 recipient mice. The number of transferred indicator T cells was then analysed by staining and fluorocytometric analysis ( Fig. 2a ) and by testing their CTL activities after restimulation in vitro (Fig. 2 b) . In addition, the virus titres were determined in spleen and thymus (Fig. 2c) . The transferred TCR+-tg cells underwent vigorous clonal expansion in the spleen of the virus-infected recipient mice up to day 6 p.i. and then declined rapidly to levels of 2.9 x 10 ~ TCR+-tg cells per spleen; the kinetics were similar to those of the endogenous CTL (Fig. 2a) . The transferred TCR+-tg cells were also analysed functionally using a secondary CTL assay (Fig. 2b) ; these experiments showed similar kinetics for endogenous and transferred TCR+-tg CTL-p. The clearance of virus from spleen and thymus of the recipient mice was not affected (Fig. 2c) by the transferred TCR+-tg cells and the LCMV C1 13-Armstrong persisted until day 100 p.i.
Factors influencing the CD8 + T cell-mediated footpad swelling reaction in C57BL/6 mice after local and systemic LCMV infection
To assess the effect of the route of virus inoculation on establishment of a persistent LCMV infection, virus was injected into the hind feet of mice. It is well established that the resulting local inflammatory reaction is mediated initially by activated LCMV-specific CD8 + and later also by CD4 + T cells (Moskophidis et al., 1989) . C57BL/6 mice infected in the footpad with LCMV C1 13-Armstrong exhibited a strong swelling of the foot in a dose-dependent fashion. Even 107p.f.u. of C1 13-Armstrong caused a very strong footpad swelling indicating that CTL activity was unimpaired. The swelling reaction was much lower, but readily detectable, in mice inoculated with LCMV-Armstrong ( Fig. 3a , upper panels).
If mice were inoculated via the footpad with l0 s p.f.u. of LCMV C1 13-Armstrong together with a systemic infection (i.v.) with an increasing dose of the same virus the footpad swelling decreased. After i.v. inoculation of 10L10 v p.f.u, of the virus, no footpad swelling could be detected (Fig. 3 a, lower panel) . In contrast, i.v. injection of LCMV-Armstrong could not reduce the LCMV-Armstrong-induced footpad swelling (Fig. 3a) . Inoculation of LCMV-Docile via the footpad into C57BL/6 mice induced swelling that was independent of the dose used. Coinjection of increasing doses of LCMV-Docile i.v., however, suppressed the footpad swelling ( Fig. 3 b) , even at 100-fold lower i.v. doses than C1 13-Armstrong.
Virus parameters regulating induction of lethal choriomeningitis in C57BL/6 mice
In further experiments we studied the development of LCM in mice after i.c. infection with different LCMV isolates. Infection of C57BL/6 with LCMV C1 13-Armstrong or its parental Armstrong isolate (102 , 104 or 106 p.f.u.) induced LCM resulting in death between days 5 and 10 p.i. Injection of 107 p.f.u. C1 13-Armstrong led to LCM and death in only 60 % of the mice tested (Fig.  4, upper panel) . Moreover, coinjections of ~> 106 p.f.u. C1 13-Armstrong i.v. with a lethal dose i.c. (104 p.f.u.), protected mice from LCM (Fig. 4, lower panel) . This protection was not seen using various doses of the parental LCMV strain Armstrong. Other results (not shown) agree with those obtained previously with LCMV-Docile; virus doses in excess of 103 p.f.u, were not able to induce LCM in C57BL/6 mice. Together, these data suggest that the ability of a virus isolate to exhaust the CTL-p in the host correlated inversely with the ability to induce CD8+-mediated local immunopathology. Armstrong LCMV isolate (Ahmed et al., 1984; Battegay et al., 1993) .
Unimpaired ability of mice infected with a high dose of LCMV to develop an antiviral antibody response

Nucleotide and amino acid comparison between LCMV isolates Docile and Aggressive in the regions of viral S-RNA comprising the relevant antiviral CTL epitope iti mice of H-2 ~ haplotype
One of several possible molecular bases for the subtle differences in phenotypes between LCMV strains with respect to the course and final outcome of the viral infection was found by analysing viral S-RNA fragments (i.e. nucleotides 4-441, 648-1010, and 2014-2205) en-coding the amino acid sequences of the relevant CTL epitope in mice of the H-2 b haplotype. Nucleotide sequences of LCMV-Docile or of LCMV-Aggressive were analysed in the regions comprising the antiviral CTL epitope defined by aa residues 3242 and 275-286 of the viral glycoprotein and the CTL epitope defined by aa residues 397405 of the nucleoprotein. Previously described nucleotide sequences of LCMV-WE, Armstrong and C1 13-Armstrong (Romanowski et al., 1985; Salvato et al., 1988) were included as references. As shown in Table 1 , there are two amino acid sequence variations between the LCMV-Docile and Aggressive S-RNA segments analysed. The change at nucleotide 216 Fig. 3 . Dose-dependence of the LCMV-specific footpad swelling reaction. (a) C57BL/6J mice were inoculated into the footpad with the indicated dose of LCMV (upper panels). Alternatively, the mice were inoculated with 106 p.f.u, into the footpad and i.v. with the indicated dose of the same virus (lower panels). Symbols: infection with LCMV C113-Armstrong (0) or Armstrong (z~). (b) Infection of C57BL/6 mice into the footpad with LCMV-Docile (A), WE (O) or Aggressive (Vq) (upper panels) or alternatively into the footpad and i.v. (lower panels). The swelling reaction was monitored by measuring the increase in thickness of the injected footpad compared with that of the footpad injected with medium only. Data points represent measurements of 5 to 10 mice; SEM values were less than 20%. results in a coding change of valine (Docile) to isoleucine Aggressive) at aa 47 of the viral glycoprotein. The alteration of nucleotide 916 changes asparagine (Aggressive) to serine (Docile) at aa 280, located within the CTL epitope 275-286 of the viral glycoprotein; the latter change prevents binding of the relevant CTL peptide H-2D b molecule (data not shown) and therefore affects induction of antiviral CTL directed against this epitope (data not shown).
Discussion
This report evaluated the capacity of different viral isolates to persist after infection of adult C57BL/6 mice. Different phenotypes of virus/host relationships were found: (i) acute infection followed by clearance within two weeks (Armstrong and WE at all doses; Docile and C1 13-Armstrong at doses less than or equal to 102 p.f.u.). (ii) temporary persistence (C1 13-Armstrong ~> 104 p.f.u.).
(iii) lifelong persistence (Docile >~ 104 p.f.u.) . These features of the LCMV infection in an immunologically competent host reflect distinct final stages of development of antiviral CTL immune responses that correspond to the above-stated phenotypes as follows: (i) activation and differentiation of the antiviral CTL-p resulting in antiviral memory CTLs, (ii) almost complete loss of the entire antiviral CTL-p repertoire and (iii) complete and permanent disappearance of CTL-p.
Exhaustion of mature peripheral T cells was thymusindependent and affected antiviral CTL-p whereas the function of CD4 + T helper cells seemed to be largely unimpaired. Irrespective of the LCMV isolate, mice developed a strong IgM or IgG antiviral response, which is CD4 + T helper cell-dependent. It is noteworthy that CD4 + T helper cells are involved in supporting CTL activities, since absence of CD4 + T cell help enhances the exhaustion of CTL substantially (Battegay et al., 1994) .
The entry route of virus had a major influence on the phenotype of infection and disease after inoculation of different LCMV isolates and doses. Inoculation of the virus subcutaneously into feet caused less pronounced suppression of antiviral CTL-p than systemic inoculation i.v. of the same virus. After subcutaneous infection the virus has to reach the lymph node before it spreads systemically via blood to reach other organs and lymphoid tissues. This slows down overall virus dis- (Romanowski et al., 1985) or Armstrong 53b and C1 13-Armstrong (Salvato et al., 1988) .
tribution to a significant extent when compared with i.v. infections; these slower kinetics prevent CTL-p exhaustion. Viral parameters that influence CTL exhaustion and virus persistence include susceptibility to interferon and replication kinetics Matloubian et al., 1993; Moskophidis et al., 1994a) dependent upon the L-RNA-encoded polymerase (Matloubian et al., 1993; Ahmed et al., 1988 b) and the cleavage site of GP, or both. Amino acid 260, which influences cleavage of the precursor GP molecule (Matloubian et al., 1990; Salvato et al., 1988 Salvato et al., , 1991 , does not differ between C1 13-Armstrong, WE, Aggressive and Docile. Therefore this cannot explain the different phenotypes. The recently defined differences in the viral L-RNA (coding for the viral polymerase) between Armstrong and CI 13-Armstrong (Matloubian et al., 1993; Ahmed et al., 1988b) are probably relevant for the phenotype of LCMV Docile. The corresponding L-segments of Docile virus have, however, not been sequenced so far, although these studies have been initiated. Here, we have found an amino acid change at residue 280 of LCMV-Docile GP that was not found in LCMV-Aggressive, which is derived from the same wild-type LCMV-WE (UBC) isolates. The impact of this change is the lack of cytotoxic activity directed to CTL epitope aa 275-286 in mice infected with LCMV-Docile and may contribute to the enhanced susceptibility to CTL exhaustion in H-2 b mice. The role of variation of amino acid 47 of the LCMV GP of Docile in comparison to Aggressive is unknown. Further comparisons of Armstrong to C1 13-Armstrong or WE reveal a substantial number of variations in the analysed viral S-RNA fragments. It is important to know that the nucleotide sequence of the original LCMV-UBC, related to WE, is not available; therefore several variations seen between LCMV-Docile or Aggressive compared with LCMV-WE may exist already in WE-UBC.
There are several additional proposed and discussed mechanisms to explain peripheral T cell unresponsiveness (Schwartz, 1990; Herman et al., 1991 ; Webb et al., 1990; Rocha &von Boehmer, 1991; Sch6nrich et al., 1991) . The following factors have been analysed and were found to be unimportant: clonal deletion of CTL-p is independent of the thymus (done, but not shown here). Antigen presentation is usually not limiting since adoptively transferred T cells expand vigorously at the time when the endogenous CTL-p have already declined or disappeared (Moskophidis et al., 1993b) . The possibility that specific CTL lyse CTL infected by LCMV or presenting LCMV peptides seems unlikely for various reasons discussed elsewhere (Moskophidis et al., 1993 b) . The role of CD4 + T helper cells and the various cytokines needs further evaluation; it has recently been shown that CD4 + T helper cells support CTL responses (Leist et al., 1989; Ahmed et al., 1988a) and that the absence ofCD4 + T helper cells enhances exhaustion (Battegay et al., 1994) .
In conclusion, this and previous studies indicate that the relative kinetics of induction and magnitude of the antiviral CTL response on one side and virus dose and the rapidity of spread of viral infection (dependent upon interferons or other factors and extent of replication of virus in lymphohaemopoietic tissues) (Gegin & Lehmann-Grube, 1992; Moskophidis et al., 1992 Moskophidis et al., , 1993 Moskophidis et al., b, 1994a Thomsen & Marker, 1989; Ahmed et al., 1991; Matloubian et al., 1993) on the other side, determine the balance between virus and immune system of the host. The LCMV isolates studied so far may be graded with respect to their capacity to establish persistent infection in adult mice; from least to greatest capacity they are Armstrong, WE and Aggressive, C1 13-Armstrong, Docile. Our results may help to explain different stages of chronic viral infections in man. Some patients with a chronic Hepatitis B virus infection lack detectable antiviral CTL-p; in contrast, those with an acute or chronic aggressive infection exhibit variable antiviral CTL activities (Penna et al., 1991; Nayersina et al., 1993) . Parameters such as the ones evaluated here, may influence crucially the subtle balance between spread of virus and antiviral immune response and thereby regulate chronic disease in the host (Nowak et al., 1991 ; Phillips et al., 1991 ; Peters et aI., 1991 ; Yoffe & Nooman, 1993) .
